Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonor Lopes

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2025
Prognostic value of [<sup>18</sup>F]FDG- and PSMA-PET in patients evaluated for [<sup>177</sup>Lu]Lu-PSMA therapy of mCRPCTugce Telli, Leonor Lopes, Madeleine Karpinski, et al.
Ebiomedicine|October 15, 2023
Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [<sup>18</sup>F]Florzolotau PET imaging and subtype/stage inference algorithmJimin Hong, Jiaying Lu, Fengtao Liu, et al.
Theranostics|July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?Alina T Küper, David Kersting, Tugce Telli, et al.
The Journal of Biological Chemistry|December 1, 2017
Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidaseElisabeth Gludovacz, Daniel Maresch, Leonor Lopes de Carvalho, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2024
Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approachLeonor Lopes, Fangyang Jiao, Song Xue, et al.
Iscience|August 11, 2023
Improved interpretation of <sup>18</sup>F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifierJiaying Lu, Christoph Clement, Jimin Hong, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2025
Prognostic value of [<sup>18</sup>F]FDG- and PSMA-PET in patients evaluated for [<sup>177</sup>Lu]Lu-PSMA therapy of mCRPCTugce Telli, Leonor Lopes, Madeleine Karpinski, et al.
Ebiomedicine|October 15, 2023
Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [<sup>18</sup>F]Florzolotau PET imaging and subtype/stage inference algorithmJimin Hong, Jiaying Lu, Fengtao Liu, et al.
Theranostics|July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?Alina T Küper, David Kersting, Tugce Telli, et al.
The Journal of Biological Chemistry|December 1, 2017
Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidaseElisabeth Gludovacz, Daniel Maresch, Leonor Lopes de Carvalho, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2024
Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approachLeonor Lopes, Fangyang Jiao, Song Xue, et al.
Iscience|August 11, 2023
Improved interpretation of <sup>18</sup>F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifierJiaying Lu, Christoph Clement, Jimin Hong, et al.
Pageof 4